USA - NASDAQ:NXGN - US65343C1027 - Common Stock
The current stock price of NXGN is 23.94 USD. In the past month the price increased by 0.55%. In the past year, price increased by 19.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31.53 | 40.00B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.74 | 9.44B | ||
| WAY | WAYSTAR HOLDING CORP | 26.67 | 6.82B | ||
| HTFL | HEARTFLOW INC | N/A | 2.57B | ||
| CERT | CERTARA INC | 17.28 | 1.39B | ||
| SDGR | SCHRODINGER INC | N/A | 1.21B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.23B | ||
| PHR | PHREESIA INC | N/A | 1.20B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 626.25 | 1.06B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.74 | 941.59M | ||
| CTEV | CLARITEV CORP | N/A | 776.07M |
NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. The company is headquartered in Irvine, California and currently employs 2,783 full-time employees. Its portfolio includes integrated solutions, which delivers on ambulatory healthcare imperatives, including consumerism, digitization, risk allocation, regulatory influence, and integrated care and health equity. Its solutions deliver care in various medical specialty in a range of practice models, including accountable care organizations (ACOs), independent physician associations (IPAs), managed service organizations (MSOs), veterans service organizations (VSOs) and dental service organizations. The company offers services across enterprise, office and insights, which include NextGen Enterprise HER, NextGen Enterprise PM, NextGen Virtual Visit, NextGen Office, NextGen Share and Mirth Connect. The company also offers data and analytics solutions, which include NextGen Health Data Hub.
NEXTGEN HEALTHCARE INC
18111 Von Karman Avenue, Suite 600
Irvine CALIFORNIA 92612 US
CEO: John R. Frantz
Employees: 2783
Phone: 19492552600.0
NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. The company is headquartered in Irvine, California and currently employs 2,783 full-time employees. Its portfolio includes integrated solutions, which delivers on ambulatory healthcare imperatives, including consumerism, digitization, risk allocation, regulatory influence, and integrated care and health equity. Its solutions deliver care in various medical specialty in a range of practice models, including accountable care organizations (ACOs), independent physician associations (IPAs), managed service organizations (MSOs), veterans service organizations (VSOs) and dental service organizations. The company offers services across enterprise, office and insights, which include NextGen Enterprise HER, NextGen Enterprise PM, NextGen Virtual Visit, NextGen Office, NextGen Share and Mirth Connect. The company also offers data and analytics solutions, which include NextGen Health Data Hub.
The current stock price of NXGN is 23.94 USD. The price increased by 0.13% in the last trading session.
NXGN does not pay a dividend.
NXGN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
NXGN stock is listed on the Nasdaq exchange.
NEXTGEN HEALTHCARE INC (NXGN) will report earnings on 2024-01-22, after the market close.
ChartMill assigns a technical rating of 8 / 10 to NXGN. When comparing the yearly performance of all stocks, NXGN is one of the better performing stocks in the market, outperforming 94.01% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to NXGN. Both the profitability and the financial health of NXGN get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months NXGN reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS increased by 33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.72% | ||
| ROE | -1.47% | ||
| Debt/Equity | 0.63 |
13 analysts have analysed NXGN and the average price target is 24.41 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 23.94.
For the next year, analysts expect an EPS growth of 14.49% and a revenue growth 11.2% for NXGN